Pacira BioSciences
PCRX
PCRX
275 hedge funds and large institutions have $3.04B invested in Pacira BioSciences in 2021 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 105 increasing their positions, 82 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 259 → 275 (+16)
3.11% more ownership
Funds ownership: 110.52% → 113.63% (+3.1%)
67% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $5.08M
Holders
275
Holding in Top 10
4
Calls
$1.67M
Puts
$5.08M
Top Buyers
| 1 | +$26.8M | |
| 2 | +$22.6M | |
| 3 | +$16.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$11.5M |
| 5 |
HCM
Hodges Capital Management
Dallas,
Texas
|
+$10.1M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$19.6M | |
| 3 | -$17.7M | |
| 4 |
Goldman Sachs
New York
|
-$15.6M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$8.12M |